Recent Headlines
Within Biological Product (except Diagnostic) Manufacturing

AnaSpec Introduces New Technical Support Solution

This month AnaSpec introduced a significantly improved online technical support resource for its website users. AnaSpec's new Frequently Asked Questions (FAQ) Page now offers a searchable database of solutions that offers a more convenient and more comprehensive solution for technical support needs. - March 22, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Phosphopeptide Standards Kit

AnaSpec has introduced a dependable tool for the analysis and characterization of phosphorylated peptides – AnaSpec’s Phosphopeptide Standards Kit. - March 19, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 58 New Antibody Products

Continuing to rapidly expand its antibody offerings, AnaSpec has added fifty-eight (58) new antibody products to its growing collection. Anti-PTEN (pSer385) (polyclonal) - Cat# 29642-025, 25 µg Host: rabbit polyclonal; Species Reactivity: human; rat; mouse; Applications: IP; WB;... - March 16, 2008 - AnaSpec, EGT Group

NCSRT Launches DiaSync for Improved Yield, Lower Cost in Harvest, Concentration, and Diafiltration of Biomolecules

At the Antibody Development and Production meeting in San Diego, CA March 12, 2008, NCSRT is launching its DiaSync process for biomolecules from fermentation, cell culture, or extraction. Utilizing concurrent processing technology and the patented SmartFlow™ TFF technology, DiaSync provides... - March 12, 2008 - NCSRT, Inc.

AnaSpec Introduces New SensoLyte™ Cathepsin D Activity Assay Kits

AnaSpec has introduced a new series of SensoLyte™ Cathepsin D Activity Assay Kits to address the issue of autofluorescence interference. - March 09, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Two Novel Amino Acids

AnaSpec has introduced two novel amino acids that offer additional tools and functionality for peptide chemists. - March 05, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 9 New Antibody Products

AnaSpec added nine new antibody products to its growing collection. - February 28, 2008 - AnaSpec, EGT Group

Former Manchester City Lord Mayor Has Hope and Quality of Life Restored at New Beike Stem Cell Facility

Shenzhen Beike Biotechnology Co., Ltd. (http://www.beikebiotech.com), the world leader in the use of umbilical cord stem cells to successfully treat a variety of illnesses, announced that Audrey Jones, the former Lord Mayor of Manchester, has returned today to the United Kingdom (UK) with... - February 26, 2008 - Shenzhen Beike Biotechnology Co., Ltd.

AnaSpec Introduces 5 New Peptide Synthesis Reagents

AnaSpec added five (5) new peptide synthesis reagents to its combinatorial chemistry collection. - February 24, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Collection of Channel Blocker Peptides

AnaSpec has introduced its selection of channel blocker peptides. - February 21, 2008 - AnaSpec, EGT Group

AnaSpec Introduces New Suite of Fluorescently Labeled GST & 6xHis Tag Antibodies

AnaSpec has introduced a suite of fluorescently labeled GST and 6X-His antibodies. These antibodies are labeled with a selection of dyes, including AnaSpec’s proprietary HiLyte FluorTM and HiLytePlusTM dyes, which span the visible spectrum. This gives researchers a wide range of wavelength... - February 16, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 46 New Antibody Products

Continuing to rapidly expand its antibody offerings, AnaSpec added forty-six (46) new antibody products to its growing collection. Anti - GST Tag AMCA labeled - Cat# 29531-AMCA, 100 µg Host: mouse monoclonal; Application: IHC Anti - GST Tag Biotin labeled - Cat# 29531-BIOT, 100... - February 13, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 21 New Anti-Tau Antibodies

AnaSpec has announced the release of 21 new anti-Tau antibodies. Complementing one of the world’s most comprehensive collections of beta-amyloid peptides, this new selection of anti-Tau antibodies demonstrates AnaSpec’s efforts to deliver new solutions for Alzheimer research. Tau is a... - February 11, 2008 - AnaSpec, EGT Group

NCSRT Presents SmartFlow™ TFF Performance Advantages Over Centrifugation and Microfiltration for Monoclonal Antibody Recovery, Concentration and Diafiltration

NCSRT is presenting “A comparison of product yield using either centrifugation and microfiltration or simultaneous membrane processing with SmartFlow™ TFF” at the Waterside Conference in Miami, FL. The data, generated by Viventia Biotech of Winnipeg, Manitoba, Canada, demonstrates... - February 08, 2008 - NCSRT, Inc.

AnaSpec Introduces 9 New Antibody Products

Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection. Anti-AKT pan (IN) - Cat# 54320, 50 µg Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; bovine; zebrafish; Applications: WB Anti-AKT pan (NT) - Cat#... - January 27, 2008 - AnaSpec, EGT Group

Xcelience Expands Its Early Drug Development Capabilities

The Tampa-based CRO is first to acquire next generation Xcelodose. - January 26, 2008 - Xcelience, LLC

AnaSpec Announces a Broad Selection of T-Cell Epitopes

AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled. - January 23, 2008 - AnaSpec, EGT Group

Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug

Enters Service Agreement with Advinus Therapeutics, India to Validate Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol. Strategy is to Bolster Caprospinol Alzheimer's Data Package to Out-License to Big Pharma and Expand IND Application to Enter Human Trials. Samaritan... - January 09, 2008 - Samaritan Pharmaceuticals

Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000

Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals

Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus

Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board

Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals

AnaSpec Introduces Ten New Catalog Peptides

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA... - January 04, 2008 - AnaSpec, EGT Group

FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study

The U.S. Food and Drug Administration (FDA) has completed its regulatory review of Samaritan's IND (Investigational New Drug) application for Cushing's syndrome SP-6300 and declared it has not identified any deficiencies in its IND filing. Accordingly, Samaritan can proceed with its proposed Phase II clinical study of Cushing's syndrome SP-6300's efficacy in patients experiencing Hypercortisolism. - January 04, 2008 - Samaritan Pharmaceuticals

Samaritan Expands Revenue Opportunities with Marketing Authorization Approval for HIV Drug Amphocil in Cyprus

Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health... - January 03, 2008 - Samaritan Pharmaceuticals

Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors

Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals

Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus

Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals

EUSA Pharma Signs Exclusive Distribution Agreement with Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus

Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals

AnaSpec Introduces Sixteen New Catalog Peptides

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine... - December 20, 2007 - AnaSpec, EGT Group

AnaSpec Introduces First Colorimetric SensoLyte™ MMP Assay Kit

AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, EGT Group

AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides

AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, EGT Group

AnaSpec Introduces 10 New Catalog Antibodies

Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2... - December 15, 2007 - AnaSpec, EGT Group

AnaSpec Releases New Antibodies Brochure

With a collection that has been rapidly expanded in the last few years, AnaSpec has organized its growing selection of antibodies into its newest antibodies brochure. The brochure showcases: • Primary antibodies • HRP, AP and biotin conjugated secondary antibodies • Patented... - December 14, 2007 - AnaSpec, EGT Group

Cardiovascular Sciences, Inc. Announces Funding Event

Cardiovascular Sciences, Inc. (CVSC), a corporation under the laws of Nevada, is excited to reveal an initial funding event with Seven Palm Investments, LLC of Illinois. After a recent assessment and restructuring of the company’s equity, the company and its investors are ready to move ahead... - December 12, 2007 - Cardiovascular Sciences, Inc.

AnaSpec Introduces Eight New Catalog Peptides and One Unusual Amino Acid

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eight (8) new catalog peptides and one new unusual amino acid. - December 07, 2007 - AnaSpec, EGT Group

AnaSpec Introduces 17 New Anti-Tau Antibodies

Continuing to rapidly expand its antibody offerings, AnaSpec added seventeen (17) new anti-Tau antibodies to its growing collection. Anti-Tau (paired181) - Cat# 54961, 50 µg Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Applications: WB Anti-Tau (paired198;199;202;205) -... - December 06, 2007 - AnaSpec, EGT Group

AnaSpec Introduces New Collection of Bcl Peptides

AnaSpec introduced a collection of peptides related to the family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle research. - December 06, 2007 - AnaSpec, EGT Group

AnaSpec Celebrates the Holidays with Its Customers

AnaSpec will be adding a one pound box of See’s Candy into every order placed from now through the end of the year. - November 29, 2007 - AnaSpec, EGT Group

AnaSpec Introduces AnaTagTM Protein Labeling Kits with HiLytePlusTM

AnaSpec introduced a new series of AnaTagTM Labeling Kits now available with the revolutionary new HiLytePlus™ series of long-wavelength dyes. - November 29, 2007 - AnaSpec, EGT Group

Samaritan Presented Favorable Caprospinol Data at Alzheimer's Drug Development Summit

In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals

AnaSpec Introduces HiLytePlus™ Labeled Secondary Antibodies & Streptavidin

AnaSpec introduces a new collection of secondary antibodies and streptavidin labeled with the new HiLytePlus™ series of fluorescent dyes. - November 17, 2007 - AnaSpec, EGT Group

AnaSpec Introduces Thirteen New Catalog Peptides

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirteen (13) new catalog peptides. Bak BH3 (71-89)- Cat# 62261 This peptide is amino acids 71 to 89 fragment of the Bak BH3 domain .The BH3 domain plays a critical role in mediating the cell death... - November 11, 2007 - AnaSpec, EGT Group

AnaSpec Introduces HiLytePlus™ – AnaSpec’s Highest Performance Fluorescent Dyes

This week AnaSpec announced the release of the HiLytePlus™ series of fluorescent dyes. Demonstrating even greater brightness than AnaSpec’s HiLyte Fluor™ line, this series represents the next generation in AnaSpec’s line of high performance fluorescent dyes. With excitation... - November 09, 2007 - AnaSpec, EGT Group

Xcelience’s Scientific Director Selected to Lead Key Sessions on Upcoming Conferences

Dr. Steve Bannister’s expertise requested for several speaking engagements over the next year - October 31, 2007 - Xcelience, LLC

NCSRT Introduces WORKS™, an Integrated Program of Products, Applications Guides, Optimization Tools, and Services

NCSRT Introduces WORKS™, an integrated program of products, applications guides, optimization tools, and services to dramatically improve downstream processing in the biopharmaceutical production environment. With the patented SmartFlow™ TFF modules and industry leading PUROSEP®... - October 30, 2007 - NCSRT, Inc.

AnaSpec Introduces Anti-Keratin-18 & 19 Antibodies

AnaSpec has introduced two new catalog antibodies: Anti-Keratin-18 and Anti-Keratin-19. Intermediate filaments (IFs), together with actin microfilaments and tubulin microtubules, comprise the three major cytoskeletal networks that are found in most eukaryotic cells.1 Keratins, which are the... - October 24, 2007 - AnaSpec, EGT Group

AnaSpec Introduces Labeled RGD Peptide for In Vivo Imaging

Leveraging its dual expertise in peptides and detection reagents, AnaSpec has released c[RGDyK(HiLyte FluorTM 750)], a labeled RGD peptide that has produced significant imaging results in a recent in vivo research study. Extracellular matrix proteins containing the Arg-Gly-Asp (RGD) motif, and... - October 18, 2007 - AnaSpec, EGT Group

AnaSpec Introduces One New Amino Acid and Two New Catalog Peptides

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced one new unusual amino acid and two new catalog peptides. HRP Prorenin; Decoy Handle Region Peptide- Cat# 62118 Sequence: RILLKKMPSV Fmoc-HomoArg(Pbf)-OH- Cat# 60004-1/ 60004-5 TP508;... - October 17, 2007 - AnaSpec, EGT Group

Recent Headlines Within Biological Product (except Diagnostic) Manufacturing

Recent Headlines
Within Biological Product (except Diagnostic) Manufacturing